首页> 外文期刊>Archives of pharmacal research >Inhibitory effect of baicalin, baicalein and wogonin on secretory group IIA phospholipase A(2)
【24h】

Inhibitory effect of baicalin, baicalein and wogonin on secretory group IIA phospholipase A(2)

机译:黄ical素,黄ical素和wogonin对IIA分泌型磷脂酶A的抑制作用(2)

获取原文
获取原文并翻译 | 示例
           

摘要

It is well known that the expression level of secretory group IIA phospholipase A(2) (sPLA(2)-IIA) is elevated in inflammatory diseases and lipopolysaccharide (LPS) up-regulates the expression of sPLA(2)-IIA in human umbilical vein endothelial cells (HUVECs). Here, three structurally related polyphenols found in the Chinese herb Huang Qui, namely baicalin, baicalein, and wogonin, were examined for its effects on the expression and activity of sPLA(2)-IIA in HUVECs and mouse. Prior treatment of cells or mouse with baicalin, baicalein, and wogonin inhibited LPS-induced expression and activity of sPLA(2)-IIA. And each compound suppressed the activation of cytosolic phospholipase A2 (cPLA2) and extracellular signal-regulated kinase (ERK) 1/2 by LPS. Therefore, these results suggest that baicalin, baicalein, and wogonin inhibited LPS mediated expression of sPLA(2)-IIA by suppression of cPLA2 and ERK 1/2.
机译:众所周知,在炎症性疾病中分泌型IIA磷脂酶A(2)(sPLA(2)-IIA)的表达水平升高,而脂多糖(LPS)上调了人脐带中sPLA(2)-IIA的表达。静脉内皮细胞(HUVEC)。在这里,检查了在中草药黄,中发现的三种与结构相关的多酚,即黄ical苷,黄e苷和wogonin,它们对sUPLAs和小鼠中sPLA(2)-IIA的表达和活性的影响。用黄ical苷,黄ical苷和沃贡宁对细胞或小鼠进行事先治疗可抑制LPS诱导的sPLA(2)-IIA的表达和活性。每种化合物均通过LPS抑制了胞质磷脂酶A2(cPLA2)和细胞外信号调节激酶(ERK)1/2的活化。因此,这些结果表明黄ical素,黄ical素和wogonin通过抑制cPLA2和ERK 1/2抑制LPS介导的sPLA(2)-IIA表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号